1887
Rapid communications Open Access
Like 0

Abstract

We describe four cases in Sweden of verified treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg; n=3) or cefotaxime (500 mg; n=1) monotherapy. All the ceftriaxone treatment failures were caused by the internationally spreading multidrug-resistant gonococcal NG-MAST genogroup 1407 clone. Increased awareness of treatment failures is crucial particularly when antimicrobial monotherapy is used. Frequent test of cure and appropriate verification/falsification of suspected treatment failures, as well as implementation of recommended dual antimicrobial therapy are imperative.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES2014.19.30.20862
2014-07-31
2017-11-21
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES2014.19.30.20862
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/19/30/art20862-en.htm?itemId=/content/10.2807/1560-7917.ES2014.19.30.20862&mimeType=html&fmt=ahah
Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error